Company Profiles

driven by the PitchBook Platform

Juventas Therapeutics

Description

Developer of regenerative therapies for cardiovascular diseases and ischemic disorders. The company's product increases cardiac function through promoting cell survival and revascularization after myocardial infarction.

2007

Founded

PRIVATE

Status

11-50

Employees

Series B2

Latest Deal Type

$13.5M

Latest Deal Amount

$49M

Total Amount Raised

Description

Developer of regenerative therapies for cardiovascular diseases and ischemic disorders. The company's product increases cardiac function through promoting cell survival and revascularization after myocardial infarction.

Website:

www.juventasinc.com

Formerly Known As

AcelleRX Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Other Devices and Supplies

Primary Office

3615 Superior Avenue Suite 4403B Cleveland, OH 44114United States +1 (216) 273-4000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Juventas Therapeutics's full profile, request a free trial.

Juventas Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Juventas Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Juventas Therapeutics Investors (18)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cleveland Clinic InnovationsVenture CapitalMinority000 0000000 0000
Early Stage PartnersVenture CapitalMinority000 0000000 0000
Fletcher Spaght VenturesVenture CapitalMinority000 0000000 0000
GlengaryVenture CapitalMinority000 0000000 0000
Global Cardiovascular Innovation CenterVenture CapitalMinority000 0000000 0000
Cleveland Clinic Innovations Venture Capital
Early Stage Partners Venture Capital
Fletcher Spaght Ventures Venture Capital
Glengary Venture Capital
Global Cardiovascular Innovation Center Venture Capital

Juventas Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Tonya JustingerDirector, Finance & Operations
Michael FitzgeraldSenior Director, Clinical Operations
Rahul Aras Ph.DCo-Founder, President, Board Member & Chief Executive Officer
Joe BaroneAssociate Director, Business Development and Analytics
Mark D'AndreaSenior Director, CMC & Quality
Tonya Justinger Director, Finance & Operations
Michael Fitzgerald Senior Director, Clinical Operations
Rahul Aras Ph.D Co-Founder, President, Board Member & Chief Executive Officer
Joe Barone Associate Director, Business Development and Analytics
Mark D'Andrea Senior Director, CMC & Quality

Juventas Therapeutics Board Members (10)

NameRepresentingRoleSinceContact
Info
George AridaVenture InvestorsAdvisor000 0000
George MateyoJuventas TherapeuticsBoard Member000 0000
James BolandJuventas TherapeuticsBoard Member000 0000
Linda TuftsFletcher Spaght VenturesFounding Partner000 0000
Marc Penn Ph.DSelfCo-Founder, Board Member & Chief Medical Officer000 0000
George Arida Advisor Venture Investors
George Mateyo Board Member Juventas Therapeutics
James Boland Board Member Juventas Therapeutics
Linda Tufts Founding Partner Fletcher Spaght Ventures
Marc Penn Ph.D Co-Founder, Board Member & Chief Medical Officer Self
Request full access to PitchBook